These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34697930)

  • 1. National Academy of Medicine of Korea (NAMOK) Key Statements on COVID-19.
    Shin HS; Park H; Kwon JS; Namgoong H; Kim SJ; Kim JM; Peck KR; Lee K; Lee JK; Lee J; Han HC; Hong S; Park BJ; Lim TH; Hwang ES; Woo JH;
    J Korean Med Sci; 2021 Oct; 36(41):e287. PubMed ID: 34697930
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
    Choi MJ; Choi WS; Seong H; Choi JY; Kim JH; Kim YJ; Cho EY; Kim DH; Park H; Lee H; Kim NJ; Song JY; Cheong HJ; Kim SI; Peck KR
    J Korean Med Sci; 2021 Jun; 36(23):e166. PubMed ID: 34128597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritizing ICU Care and Legal Liability During the COVID-19 Crisis in Korea.
    Park HW
    J Korean Med Sci; 2022 Feb; 37(5):e43. PubMed ID: 35132845
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 public health investigation in an aged care facility and challenges with serological screening in low pre-test probability settings.
    Smoll NR; Taylor C; Martin R; Wheatley S; Moore P; Finger M; Moore F; Schlebusch S; Khandaker G
    Commun Dis Intell (2018); 2021 Aug; 45():. PubMed ID: 34493179
    [No Abstract]   [Full Text] [Related]  

  • 5. Public Health Strategies Contain and Mitigate COVID-19: A Tale of Two Democracies.
    Solano JJ; Maki DG; Adirim TA; Shih RD; Hennekens CH
    Am J Med; 2020 Dec; 133(12):1365-1366. PubMed ID: 32810463
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
    Min KD; Tak S
    Epidemiol Health; 2021; 43():e2021040. PubMed ID: 34082498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covid-19 vaccine hesitancy among ethnic minority groups.
    Razai MS; Osama T; McKechnie DGJ; Majeed A
    BMJ; 2021 Feb; 372():n513. PubMed ID: 33637577
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 vaccines approved in the European Union: current evidence and perspectives.
    Bellino S
    Expert Rev Vaccines; 2021 Oct; 20(10):1195-1199. PubMed ID: 34338126
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    Joffe S
    JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
    [No Abstract]   [Full Text] [Related]  

  • 10. A Long Way to the Recovery: COVID-19 Will Not Disappear.
    Jung J
    J Korean Med Sci; 2021 Aug; 36(32):e231. PubMed ID: 34402229
    [No Abstract]   [Full Text] [Related]  

  • 11. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2.
    Majdoubi A; Michalski C; O'Connell SE; Dada S; Narpala S; Gelinas J; Mehta D; Cheung C; Winkler DF; Basappa M; Liu AC; Görges M; Barakauskas VE; Irvine M; Mehalko J; Esposito D; Sekirov I; Jassem AN; Goldfarb DM; Pelech S; Douek DC; McDermott AB; Lavoie PM
    JCI Insight; 2021 Apr; 6(8):. PubMed ID: 33720905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shortcomings of the Korean Government's Policies to Combat the COVID-19 Pandemic and Suggestions for Improvement.
    Ma SH
    J Korean Med Sci; 2021 May; 36(21):e156. PubMed ID: 34060262
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Return to Normal Is Not Good Enough.
    Elkind MSV; Harrington RA; Lloyd-Jones DM
    Circulation; 2021 May; 143(18):e893-e897. PubMed ID: 33939527
    [No Abstract]   [Full Text] [Related]  

  • 15. Academic Community's Efforts to Guide the Fight Against Coronavirus Disease 2019 (COVID-19) Epidemic in Korea.
    Cho SI
    J Prev Med Public Health; 2020 Mar; 53(2):65-66. PubMed ID: 32268457
    [No Abstract]   [Full Text] [Related]  

  • 16. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the UK vaccinate children and adolescents against covid-19?
    Saxena S; Skirrow H; Wighton K
    BMJ; 2021 Jul; 374():n1866. PubMed ID: 34301635
    [No Abstract]   [Full Text] [Related]  

  • 18. A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    Gostin LO
    JAMA; 2021 Jan; 325(1):17-18. PubMed ID: 33399836
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
    Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
    Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.